Olympus Set to Demonstrate Newest Endoscopy System at DDW

Olympus Corporation, a global medical technology company committed to making people’s lives healthier, safer and more fulfilling, announced that, for the first time in the U.S., it will demonstrate the EVIS X1™ endoscopy system, its most advanced endoscopy system, at the Digestive Disease Week (DDW) annual meeting May 6-9 in Chicago.

The EVIS X1 endoscopy system recently received FDA 510(k) clearance along with two compatible gastrointestinal endoscopes: the GIF-1100 gastrointestinal videoscope indicated for use within the upper digestive tract and the CF-HQ1100DL/I colonovideoscope indicated for use within the lower digestive tract, which will also be displayed. The lightweight ErgoGrip control section of these endoscopes has a rounded handle and easy-to-reach angulation control knobs and switches to accommodate users with small hands and support scope maneuverability.

Features of the EVIS X1 endoscopy system² include:

• Texture and Color Enhancement Imaging: TXI™ technology is designed to increase the visibility of lesions and polyps by enhancing image color and texture.
• Red Dichromatic Imaging: RDI™ technology is designed to enhance the visibility of deep blood vessels and bleeding points.

Also Read: HelpMeSee announces global launch of next-generation simulation-based eye surgery training for phacoemulsification

• Brightness Adjustment Imaging with Maintenance of Contrast: BAI-MAC™ technology is designed to correct the brightness levels in dark areas of the endoscopic image, while maintaining the brightness of lighter areas, to increase the total distance view.
• Narrow Band Imaging™: NBI™ technology continues to be featured in the EVIS X1 endoscopy system. NBI technology enhances visual observation of mucosal and vascular patterns by utilizing specific blue and green wavelengths absorbed by hemoglobin.³

“We are very excited to share the advancements of our newest endoscopy system with gastroenterologists at the annual DDW meeting,” said Richard Reynolds, President of the Medical Systems Group for Olympus America, Inc. “As a leading MedTech company, Olympus is driven to provide cutting-edge endoscopy systems that help physicians offer their patients the best care possible.”

TXI, RDI, BAI-MAC and NBI technologies are not intended to replace histopathological sampling as a means of diagnosis. These are adjunctive tools for endoscopic examination that can be used to supplement Olympus white light imaging.

SOURCE: PR Newswire